ArticleJournal of gastrointestinal cancer2017

A Cost-Effectiveness Analysis of Gemcitabine plus Cisplatin Versus Gemcitabine Alone for Treatment of Advanced Biliary Tract Cancer in Japan.

Ikuto Tsukiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.